Oligonucleotide Treatment for Huntington's Disease.

Fischbeck, Kenneth H; Wexler, Nancy S

Fischbeck, Kenneth H; Wexler, Nancy S.

Afiliação

Fischbeck KH; From the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD (K.H.F.); and the Departments of Neurology and Psychiatry, College of Physicians and Surgeons, Columbia University and Hereditary Disease Foundation, New York (N.S.W.).
Wexler NS; From the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD (K.H.F.); and the Departments of Neurology and Psychiatry, College of Physicians and Surgeons, Columbia University and Hereditary Disease Foundation, New York (N.S.W.).

N Engl J Med ; 380(24): 2373-2374, 2019 06 13.

Article em En | MEDLINE | ID: mdl-31059640

Assuntos

Proteína Huntingtina; Doença de Huntington; Humanos; Proteína Huntingtina/metabolismo; Oligonucleotídeos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Huntington / Proteína Huntingtina Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google